Verrica Pharmaceutical
IPOVerrica Pharmaceuticals
Public · United States
- Business Model
- B2B
- Website
- verrica.com
- Last Round
- SeedDec 2015
- Rounds
- 1
- Type
- Public
About
Biopharmaceutical company developing dermatology treatments, including VP-102 (Ycanth) approved by the FDA for molluscum contagiosum.
Summary
Verrica Pharmaceutical is a Biotech company based in United States. Its most recent funding was a Seed round in Dec 2015.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Nov 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Specialty pharmaceutical company